Gordon H. Busenbark
Directeur Financier/CFO chez Cianna Medical, Inc.
Profil
Gordon H.
Busenbark is currently the Chief Financial Officer at Cianna Medical, Inc. He previously held positions as Director at Nventa Biopharmaceuticals Corp.
and Akela Pharma, Inc. He was also the Vice President-Global Quality at Baxter Healthcare Corp.
from 1998 to 2003 and the Chief Financial Officer at Encysive Pharmaceuticals, Inc. from 2007 to 2009.
Additionally, he served as the Chief Financial Officer at Xytis, Inc., Inspiration Biopharmaceuticals, Inc., and Immuno AG.
Mr. Busenbark received his undergraduate and MBA degrees from the University of Utah in 1979.
Postes actifs de Gordon H. Busenbark
| Sociétés | Poste | Début |
|---|---|---|
Cianna Medical, Inc.
 Cianna Medical, Inc. Medical SpecialtiesHealth Technology Cianna Medical, Inc. manufactures and marketing equipment for the treatment of early-stage breast cancer in women. The firm’s products include SAVI, a breast brachytherapy applicator used for the delivery of radiation after lumpectomy surgery; and SAVI SCOUT, a surgical guidance system that uses real-time audible and visual indicators to give surgeons a precise way to target tissue during lumpectomy and excisional biopsy procedures. The company was founded in 2007 and is headquartered in Aliso Viejo, CA. | Directeur Financier/CFO | - |
Anciens postes connus de Gordon H. Busenbark
| Sociétés | Poste | Fin |
|---|---|---|
Xytis, Inc.
 Xytis, Inc. BiotechnologyHealth Technology Xytis, Inc. was engaged in the development of central nervous system. The company was founded by Werner Tschollar in January 2006 and was headquartered in Irvine, CA. | Directeur Financier/CFO | 01/10/2009 |
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Directeur Financier/CFO | 01/10/2009 |
Nventa Biopharmaceuticals Corp.
 Nventa Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Nventa Biopharmaceuticals Corp. discovered, developed and commercialized stress protein-based therapeutic vaccines. The company was headquartered in Victoria, Canada. | Directeur/Membre du Conseil | 22/05/2009 |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | 01/01/2003 |
| Immuno AG | Directeur Financier/CFO | - |
Formation de Gordon H. Busenbark
| University of Utah | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Health Technology |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Health Technology |
Nventa Biopharmaceuticals Corp.
Nventa Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Nventa Biopharmaceuticals Corp. discovered, developed and commercialized stress protein-based therapeutic vaccines. The company was headquartered in Victoria, Canada. | Health Technology |
Xytis, Inc.
Xytis, Inc. BiotechnologyHealth Technology Xytis, Inc. was engaged in the development of central nervous system. The company was founded by Werner Tschollar in January 2006 and was headquartered in Irvine, CA. | Health Technology |
Inspiration Biopharmaceuticals, Inc.
 Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Inspiration Biopharmaceuticals, Inc. produces intravenous recombinant therapies and develops non-invasive applications. It offers its products for the hemophilia community. The company was founded by Scott Donnelly Martin and John Read Taylor, Jr. on April 28, 2006 and is headquartered in Boston, MA. | Health Technology |
Akela Pharma, Inc.
 Akela Pharma, Inc. Pharmaceuticals: MajorHealth Technology Akela Pharma, Inc. operates as a drug development company, which develops and manufactures pharmaceutical formulations and drugs. The company operates as a specialty contract pharmaceutical formulation developer and clinical and commercial drug manufacturer for proprietary drug products through its wholly-owned subsidiary, PharmaForm LLC, a pharmaceutical intellectual property development company. It provides specialty contract services in the area of pharmaceutical dosage form development, preclinical, scale-up, clinical and commercial supply manufacturing, focusing on controlled release and bioavailability enhancement technologies, such as hot melt extrusion, spray drying and liquid filled capsules. Akela Pharma was founded on November 15, 1988 and is headquartered in Austin, TX. | Health Technology |
Cianna Medical, Inc.
Cianna Medical, Inc. Medical SpecialtiesHealth Technology Cianna Medical, Inc. manufactures and marketing equipment for the treatment of early-stage breast cancer in women. The firm’s products include SAVI, a breast brachytherapy applicator used for the delivery of radiation after lumpectomy surgery; and SAVI SCOUT, a surgical guidance system that uses real-time audible and visual indicators to give surgeons a precise way to target tissue during lumpectomy and excisional biopsy procedures. The company was founded in 2007 and is headquartered in Aliso Viejo, CA. | Health Technology |
| Immuno AG |
